[PHARMA] YoY Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -36.04%
YoY- -85.14%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 515,215 524,413 502,086 440,807 426,460 371,432 334,337 7.46%
PBT 19,923 25,337 24,945 13,461 28,493 15,646 15,405 4.37%
Tax -7,275 -5,362 -9,944 -9,291 -2,957 -4,687 -6,970 0.71%
NP 12,648 19,975 15,001 4,170 25,536 10,959 8,435 6.97%
-
NP to SH 13,061 19,971 14,955 3,751 25,247 10,811 8,586 7.23%
-
Tax Rate 36.52% 21.16% 39.86% 69.02% 10.38% 29.96% 45.25% -
Total Cost 502,567 504,438 487,085 436,637 400,924 360,473 325,902 7.47%
-
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.80%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 10,365 23,312 20,698 7,760 11,764 - - -
Div Payout % 79.37% 116.73% 138.41% 206.90% 46.60% - - -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.80%
NOSH 259,146 259,027 258,737 258,689 117,646 106,933 106,924 15.88%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.45% 3.81% 2.99% 0.95% 5.99% 2.95% 2.52% -
ROE 2.46% 3.74% 2.95% 0.79% 5.09% 2.33% 2.02% -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 198.81 202.45 194.05 170.40 362.49 347.35 312.69 -7.26%
EPS 5.04 7.71 5.78 1.45 21.46 10.11 8.03 -7.46%
DPS 4.00 9.00 8.00 3.00 10.00 0.00 0.00 -
NAPS 2.05 2.063 1.96 1.83 4.22 4.34 3.97 -10.42%
Adjusted Per Share Value based on latest NOSH - 258,689
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 35.75 36.39 34.84 30.58 29.59 25.77 23.20 7.46%
EPS 0.91 1.39 1.04 0.26 1.75 0.75 0.60 7.18%
DPS 0.72 1.62 1.44 0.54 0.82 0.00 0.00 -
NAPS 0.3686 0.3708 0.3519 0.3285 0.3445 0.322 0.2945 3.80%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 5.58 6.50 4.63 4.82 7.55 5.90 4.98 -
P/RPS 2.81 3.21 2.39 2.83 2.08 1.70 1.59 9.94%
P/EPS 110.71 84.31 80.10 332.41 35.18 58.36 62.02 10.12%
EY 0.90 1.19 1.25 0.30 2.84 1.71 1.61 -9.23%
DY 0.72 1.38 1.73 0.62 1.32 0.00 0.00 -
P/NAPS 2.72 3.15 2.36 2.63 1.79 1.36 1.25 13.82%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 -
Price 5.70 6.50 4.45 4.72 8.25 5.90 4.92 -
P/RPS 2.87 3.21 2.29 2.77 2.28 1.70 1.57 10.56%
P/EPS 113.10 84.31 76.99 325.52 38.44 58.36 61.27 10.74%
EY 0.88 1.19 1.30 0.31 2.60 1.71 1.63 -9.75%
DY 0.70 1.38 1.80 0.64 1.21 0.00 0.00 -
P/NAPS 2.78 3.15 2.27 2.58 1.95 1.36 1.24 14.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment